
Successful treatment of HIV‐associated lupus‐like glomerulonephritis with mycophenolic acid
Author(s) -
Tiong Mark,
Wilson Scott,
Pham Alan,
Chrysostomou Anastasia
Publication year - 2020
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.2955
Subject(s) - medicine , mycophenolic acid , viremia , systemic lupus erythematosus , glomerulonephritis , human immunodeficiency virus (hiv) , immunology , mycophenolate , antiretroviral therapy , immunosuppression , disease , transplantation , viral load , kidney
HIV‐associated lupus‐like glomerulonephritis is an uncommon but well‐described entity. Treatment has traditionally focused on control of HIV viremia with some using adjuvant steroids. Mycophenolic acid may prove to be a novel, nonsteroid, therapy in patients with active glomerulonephritis despite control of the underlying infection.